Risk factors for unfavorable outcome of pulmonary tuberculosis in adults in Taipei, Taiwan

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 5, 2012, Pages 303-308

  Yen, Yung Feng ^a   Yen, Muh Yong ^a   Shih, Hsiu Chen ^a   Deng, Chung Yeh ^b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Multivariate analysis; Risk factors; Surveillance; Taiwan; Treatment outcome; Tuberculosis

Indexed keywords

ACID FAST BACTERIUM; ADULT; AGED; ARTICLE; DEATH; EDUCATIONAL STATUS; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; KIDNEY FAILURE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MARRIAGE; MEDICAL HISTORY; MULTIDRUG RESISTANT TUBERCULOSIS; PLEURA EFFUSION; RELAPSE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; TAIWAN; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME; UNEMPLOYMENT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; COHORT STUDIES; EARLY DIAGNOSIS; EDUCATIONAL STATUS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; QUESTIONNAIRES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; TAIWAN; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84859834218     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2012.01.011     Document Type: Article

References (30)

1. Frieden T.R., Sterling T.R., Munsiff S.S., Watt C.J., Dye C. Tuberculosis. Lancet 2003, 362:887-899.
2. WHO. Tuberculosis (TB). Geneva: World Health Organization; 2010. [accessed 18 September 2010]. http://www.who.int/tb/country/data/download/en/index.html.
3. Jensen P.A., Lambert L.A., Iademarco M.F., Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005, 54:1-141.
4. WHO. Tuberculosis programme. Framework for effective tuberculosis control. Geneva, Switzerland: World Health Organization; 1991. WHO/TB/94.179.
5. Taiwan Centers for Disease Control and Prevention. [Promulgated definitions of TB]. Taipei, Taiwan: CDC. [accessed 8 August 2010] [Chinese]. http://www.cdc.gov.tw/.
6. Abuaku B., Tan H., Li X., Chen M., Huang X. Treatment default and death among tuberculosis patients in Hunan, China. Scand J Infect Dis 2010, 42:281-287.
7. Tessema B., Muche A., Bekele A., Reissig D., Emmrich F., Sack U. Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five-year retrospective study. BMC Public Health 2009, 9:371.
8. Chiang C.Y., Lee J.J., Yu M.C., Enarson D.A., Lin T.P., Luh K.T. Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis 2009, 13:105-111.
9. Lee J.J., Wu R.L., Lee Y.S., Wu Y.C., Chiang C.Y. Treatment outcome of pulmonary tuberculosis in eastern Taiwan - experience at a medical center. J Formos Med Assoc 2007, 106:25-30.
10. Farah M.G., Tverdal A., Steen T.W., Heldal E., Brantsaeter A.B., Bjune G. Treatment outcome of new culture positive pulmonary tuberculosis in Norway. BMC Public Health 2005, 5:14.
11. Falzon D., Le Strat Y., Belghiti F., Infuso A. Exploring the determinants of treatment success for tuberculosis cases in Europe. Int J Tuberc Lung Dis 2005, 9:1224-1229.
12. Cayla J.A., Caminero J.A., Rey R., Lara N., Valles X., Galdos-Tanguis H. Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberc Lung Dis 2004, 8:458-464.
13. Kliiman K., Altraja A. Predictors and mortality associated with treatment default in pulmonary tuberculosis. Int J Tuberc Lung Dis 2010, 14:454-463.
14. Dewan P.K., Arguin P.M., Kiryanova H., et al. Risk factors for death during tuberculosis treatment in Orel, Russia. Int J Tuberc Lung Dis 2004, 8:598-602.
15. Pablos-Mendez A., Sterling T.R., Frieden T.R. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 1996, 276:1223-1228.
16. Aparna S.B., Reddy V.C., Gokhale S., Moorthy K.V. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India. Trans R Soc Trop Med Hyg 2009, 103:564-570.
17. Kourbatova E.V., Borodulin B.E., Borodulina E.A., del Rio C., Blumberg H.M., Leonard M.K. Risk factors for mortality among adult patients with newly diagnosed tuberculosis in Samara, Russia. Int J Tuberc Lung Dis 2006, 10:1224-1230.
18. Silva D.R., Menegotto D.M., Schulz L.F., Gazzana M.B., Dalcin Pde T. Factors associated with mortality in hospitalized patients with newly diagnosed tuberculosis. Lung 2010, 188:33-41.
19. WHO. Global tuberculosis control. WHO Report 1999. Geneva, Switzerland: World Health Organization; 1999. WHO/CDS/CPC/TB/99.259.
20. Jasmer R.M., Seaman C.B., Gonzalez L.C., Kawamura L.M., Osmond D.H., Daley C.L. Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy. Am J Respir Crit Care Med 2004, 170:561-566.
21. Younis M.Z., Rivers P.A., Fottler M.D. The impact of HMO and hospital competition on hospital costs. J Health Care Finance 2005, 31:60-74.
22. Berisha M., Zheki V., Zadzhmi D., Gashi S., Hokha R., Begoli I. Level of knowledge regarding tuberculosis and stigma among patients suffering from tuberculosis. Georgian Med News 2009, 166:89-93.
23. Lu S.H., Tian B.C., Kang X.P., et al. Public awareness of tuberculosis in China: a national survey of 69 253 subjects. Int J Tuberc Lung Dis 2009, 13:1493-1499.
24. Hoa N.P., Diwan V.K., Co N.V., Thorson A.E. Knowledge about tuberculosis and its treatment among new pulmonary TB patients in the north and central regions of Vietnam. Int J Tuberc Lung Dis 2004, 8:603-608.
25. Elzinga G., Raviglione M.C., Maher D. Scale up: meeting targets in global tuberculosis control. Lancet 2004, 363:814-819.
26. Okanurak K., Kitayaporn D., Akarasewi P. Factors contributing to treatment success among tuberculosis patients: a prospective cohort study in Bangkok. Int J Tuberc Lung Dis 2008, 12:1160-1165.
27. Pepper D.J., Marais S., Wilkinson R.J., Bhaijee F., De Azevedo V., Meintjes G. Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa. PLoS One 2011, 6:e19484.
28. Department of Health, Executive Yuan, Taiwan. [accessed 15 October 2010] [Chinese]. http://www.doh.gov.tw/.
29. Cheng S.H., Chiang T.L. The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment. JAMA 1997, 278:89-93.
30. UNAIDS. Report on the global HIV/AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2009.